1 Study Coverage
    1.1 Human Rotavirus Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Human Rotavirus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Rotarix
        1.2.3 RotaTeq
        1.2.4 Rotavac
        1.2.5 Rotavin-M1
        1.2.6 Lanzhou lamb
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Human Rotavirus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals & Clinics
        1.3.3 Academic And Research
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Human Rotavirus Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global Human Rotavirus Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Human Rotavirus Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Human Rotavirus Vaccine Sales by Region
        2.4.1 Global Human Rotavirus Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Human Rotavirus Vaccine by Region (2023-2028)
    2.5 Global Human Rotavirus Vaccine Revenue by Region
        2.5.1 Global Human Rotavirus Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Human Rotavirus Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Human Rotavirus Vaccine Sales by Manufacturers
        3.1.1 Global Top Human Rotavirus Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Human Rotavirus Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Rotavirus Vaccine in 2021
    3.2 Global Human Rotavirus Vaccine Revenue by Manufacturers
        3.2.1 Global Human Rotavirus Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Human Rotavirus Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Human Rotavirus Vaccine Revenue in 2021
    3.3 Global Human Rotavirus Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Human Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Human Rotavirus Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Human Rotavirus Vaccine Sales by Type
        4.1.1 Global Human Rotavirus Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Human Rotavirus Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global Human Rotavirus Vaccine Revenue by Type
        4.2.1 Global Human Rotavirus Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Human Rotavirus Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Human Rotavirus Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global Human Rotavirus Vaccine Price by Type
        4.3.1 Global Human Rotavirus Vaccine Price by Type (2017-2022)
        4.3.2 Global Human Rotavirus Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Human Rotavirus Vaccine Sales by Application
        5.1.1 Global Human Rotavirus Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Human Rotavirus Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global Human Rotavirus Vaccine Revenue by Application
        5.2.1 Global Human Rotavirus Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Human Rotavirus Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Human Rotavirus Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global Human Rotavirus Vaccine Price by Application
        5.3.1 Global Human Rotavirus Vaccine Price by Application (2017-2022)
        5.3.2 Global Human Rotavirus Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Human Rotavirus Vaccine Market Size by Type
        6.1.1 North America Human Rotavirus Vaccine Sales by Type (2017-2028)
        6.1.2 North America Human Rotavirus Vaccine Revenue by Type (2017-2028)
    6.2 North America Human Rotavirus Vaccine Market Size by Application
        6.2.1 North America Human Rotavirus Vaccine Sales by Application (2017-2028)
        6.2.2 North America Human Rotavirus Vaccine Revenue by Application (2017-2028)
    6.3 North America Human Rotavirus Vaccine Market Size by Country
        6.3.1 North America Human Rotavirus Vaccine Sales by Country (2017-2028)
        6.3.2 North America Human Rotavirus Vaccine Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Human Rotavirus Vaccine Market Size by Type
        7.1.1 Europe Human Rotavirus Vaccine Sales by Type (2017-2028)
        7.1.2 Europe Human Rotavirus Vaccine Revenue by Type (2017-2028)
    7.2 Europe Human Rotavirus Vaccine Market Size by Application
        7.2.1 Europe Human Rotavirus Vaccine Sales by Application (2017-2028)
        7.2.2 Europe Human Rotavirus Vaccine Revenue by Application (2017-2028)
    7.3 Europe Human Rotavirus Vaccine Market Size by Country
        7.3.1 Europe Human Rotavirus Vaccine Sales by Country (2017-2028)
        7.3.2 Europe Human Rotavirus Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Human Rotavirus Vaccine Market Size by Type
        8.1.1 Asia Pacific Human Rotavirus Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Human Rotavirus Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific Human Rotavirus Vaccine Market Size by Application
        8.2.1 Asia Pacific Human Rotavirus Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Human Rotavirus Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific Human Rotavirus Vaccine Market Size by Region
        8.3.1 Asia Pacific Human Rotavirus Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Human Rotavirus Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Human Rotavirus Vaccine Market Size by Type
        9.1.1 Latin America Human Rotavirus Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America Human Rotavirus Vaccine Revenue by Type (2017-2028)
    9.2 Latin America Human Rotavirus Vaccine Market Size by Application
        9.2.1 Latin America Human Rotavirus Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America Human Rotavirus Vaccine Revenue by Application (2017-2028)
    9.3 Latin America Human Rotavirus Vaccine Market Size by Country
        9.3.1 Latin America Human Rotavirus Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America Human Rotavirus Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Human Rotavirus Vaccine Market Size by Type
        10.1.1 Middle East and Africa Human Rotavirus Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Human Rotavirus Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Human Rotavirus Vaccine Market Size by Application
        10.2.1 Middle East and Africa Human Rotavirus Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Human Rotavirus Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Human Rotavirus Vaccine Market Size by Country
        10.3.1 Middle East and Africa Human Rotavirus Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Human Rotavirus Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bharat Biotech
        11.1.1 Bharat Biotech Corporation Information
        11.1.2 Bharat Biotech Overview
        11.1.3 Bharat Biotech Human Rotavirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bharat Biotech Human Rotavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bharat Biotech Recent Developments
    11.2 Merck
        11.2.1 Merck Corporation Information
        11.2.2 Merck Overview
        11.2.3 Merck Human Rotavirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Merck Human Rotavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Merck Recent Developments
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Corporation Information
        11.3.2 GlaxoSmithKline Overview
        11.3.3 GlaxoSmithKline Human Rotavirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 GlaxoSmithKline Human Rotavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 GlaxoSmithKline Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Human Rotavirus Vaccine Industry Chain Analysis
    12.2 Human Rotavirus Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Human Rotavirus Vaccine Production Mode & Process
    12.4 Human Rotavirus Vaccine Sales and Marketing
        12.4.1 Human Rotavirus Vaccine Sales Channels
        12.4.2 Human Rotavirus Vaccine Distributors
    12.5 Human Rotavirus Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Human Rotavirus Vaccine Industry Trends
    13.2 Human Rotavirus Vaccine Market Drivers
    13.3 Human Rotavirus Vaccine Market Challenges
    13.4 Human Rotavirus Vaccine Market Restraints
14 Key Findings in The Global Human Rotavirus Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Human Rotavirus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Rotarix
    Table 3. Major Manufacturers of RotaTeq
    Table 4. Major Manufacturers of Rotavac
    Table 5. Major Manufacturers of Rotavin-M1
    Table 6. Major Manufacturers of Lanzhou lamb
    Table 7. Major Manufacturers of Others
    Table 8. Global Human Rotavirus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Human Rotavirus Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Human Rotavirus Vaccine Sales by Region (2017-2022) & (K Units)
    Table 11. Global Human Rotavirus Vaccine Sales Market Share by Region (2017-2022)
    Table 12. Global Human Rotavirus Vaccine Sales by Region (2023-2028) & (K Units)
    Table 13. Global Human Rotavirus Vaccine Sales Market Share by Region (2023-2028)
    Table 14. Global Human Rotavirus Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Human Rotavirus Vaccine Revenue Market Share by Region (2017-2022)
    Table 16. Global Human Rotavirus Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 17. Global Human Rotavirus Vaccine Revenue Market Share by Region (2023-2028)
    Table 18. Global Human Rotavirus Vaccine Sales by Manufacturers (2017-2022) & (K Units)
    Table 19. Global Human Rotavirus Vaccine Sales Share by Manufacturers (2017-2022)
    Table 20. Global Human Rotavirus Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 21. Global Human Rotavirus Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 22. Human Rotavirus Vaccine Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 23. Global Human Rotavirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Human Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rotavirus Vaccine as of 2021)
    Table 25. Human Rotavirus Vaccine Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Human Rotavirus Vaccine Product Offered
    Table 27. Date of Manufacturers Enter into Human Rotavirus Vaccine Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
    Table 30. Global Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
    Table 31. Global Human Rotavirus Vaccine Sales Share by Type (2017-2022)
    Table 32. Global Human Rotavirus Vaccine Sales Share by Type (2023-2028)
    Table 33. Global Human Rotavirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Global Human Rotavirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Global Human Rotavirus Vaccine Revenue Share by Type (2017-2022)
    Table 36. Global Human Rotavirus Vaccine Revenue Share by Type (2023-2028)
    Table 37. Human Rotavirus Vaccine Price by Type (2017-2022) & (USD/Unit)
    Table 38. Global Human Rotavirus Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 39. Global Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
    Table 40. Global Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
    Table 41. Global Human Rotavirus Vaccine Sales Share by Application (2017-2022)
    Table 42. Global Human Rotavirus Vaccine Sales Share by Application (2023-2028)
    Table 43. Global Human Rotavirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 44. Global Human Rotavirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 45. Global Human Rotavirus Vaccine Revenue Share by Application (2017-2022)
    Table 46. Global Human Rotavirus Vaccine Revenue Share by Application (2023-2028)
    Table 47. Human Rotavirus Vaccine Price by Application (2017-2022) & (USD/Unit)
    Table 48. Global Human Rotavirus Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 49. North America Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
    Table 50. North America Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
    Table 51. North America Human Rotavirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 52. North America Human Rotavirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 53. North America Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
    Table 54. North America Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
    Table 55. North America Human Rotavirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 56. North America Human Rotavirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 57. North America Human Rotavirus Vaccine Sales by Country (2017-2022) & (K Units)
    Table 58. North America Human Rotavirus Vaccine Sales by Country (2023-2028) & (K Units)
    Table 59. North America Human Rotavirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 60. North America Human Rotavirus Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Europe Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
    Table 62. Europe Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
    Table 63. Europe Human Rotavirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 64. Europe Human Rotavirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 65. Europe Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
    Table 66. Europe Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
    Table 67. Europe Human Rotavirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 68. Europe Human Rotavirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 69. Europe Human Rotavirus Vaccine Sales by Country (2017-2022) & (K Units)
    Table 70. Europe Human Rotavirus Vaccine Sales by Country (2023-2028) & (K Units)
    Table 71. Europe Human Rotavirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 72. Europe Human Rotavirus Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
    Table 74. Asia Pacific Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
    Table 75. Asia Pacific Human Rotavirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Human Rotavirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
    Table 78. Asia Pacific Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
    Table 79. Asia Pacific Human Rotavirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Human Rotavirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Human Rotavirus Vaccine Sales by Region (2017-2022) & (K Units)
    Table 82. Asia Pacific Human Rotavirus Vaccine Sales by Region (2023-2028) & (K Units)
    Table 83. Asia Pacific Human Rotavirus Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Human Rotavirus Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 85. Latin America Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
    Table 86. Latin America Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
    Table 87. Latin America Human Rotavirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Latin America Human Rotavirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 89. Latin America Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
    Table 90. Latin America Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
    Table 91. Latin America Human Rotavirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 92. Latin America Human Rotavirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 93. Latin America Human Rotavirus Vaccine Sales by Country (2017-2022) & (K Units)
    Table 94. Latin America Human Rotavirus Vaccine Sales by Country (2023-2028) & (K Units)
    Table 95. Latin America Human Rotavirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 96. Latin America Human Rotavirus Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
    Table 98. Middle East and Africa Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
    Table 99. Middle East and Africa Human Rotavirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Human Rotavirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
    Table 102. Middle East and Africa Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
    Table 103. Middle East and Africa Human Rotavirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Human Rotavirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Human Rotavirus Vaccine Sales by Country (2017-2022) & (K Units)
    Table 106. Middle East and Africa Human Rotavirus Vaccine Sales by Country (2023-2028) & (K Units)
    Table 107. Middle East and Africa Human Rotavirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Human Rotavirus Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 109. Bharat Biotech Corporation Information
    Table 110. Bharat Biotech Description and Major Businesses
    Table 111. Bharat Biotech Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. Bharat Biotech Human Rotavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Bharat Biotech Recent Developments
    Table 114. Merck Corporation Information
    Table 115. Merck Description and Major Businesses
    Table 116. Merck Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Merck Human Rotavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Merck Recent Developments
    Table 119. GlaxoSmithKline Corporation Information
    Table 120. GlaxoSmithKline Description and Major Businesses
    Table 121. GlaxoSmithKline Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. GlaxoSmithKline Human Rotavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. GlaxoSmithKline Recent Developments
    Table 124. Key Raw Materials Lists
    Table 125. Raw Materials Key Suppliers Lists
    Table 126. Human Rotavirus Vaccine Distributors List
    Table 127. Human Rotavirus Vaccine Customers List
    Table 128. Human Rotavirus Vaccine Market Trends
    Table 129. Human Rotavirus Vaccine Market Drivers
    Table 130. Human Rotavirus Vaccine Market Challenges
    Table 131. Human Rotavirus Vaccine Market Restraints
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Rotavirus Vaccine Product Picture
    Figure 3. Global Human Rotavirus Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Rotarix Product Picture
    Figure 4. RotaTeq Product Picture
    Figure 5. Rotavac Product Picture
    Figure 6. Rotavin-M1 Product Picture
    Figure 7. Lanzhou lamb Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Human Rotavirus Vaccine Market Share by Application in 2021 & 2028
    Figure 10. Hospitals & Clinics
    Figure 11. Academic And Research
    Figure 12. Others
    Figure 13. Human Rotavirus Vaccine Report Years Considered
    Figure 14. Global Human Rotavirus Vaccine Sales 2017-2028 (K Units)
    Figure 15. Global Human Rotavirus Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Human Rotavirus Vaccine Revenue 2017-2028 (US$ Million)
    Figure 17. Global Human Rotavirus Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Human Rotavirus Vaccine Sales Market Share by Region (2017-2022)
    Figure 19. Global Human Rotavirus Vaccine Sales Market Share by Region (2023-2028)
    Figure 20. North America Human Rotavirus Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 21. North America Human Rotavirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Human Rotavirus Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe Human Rotavirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Human Rotavirus Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific Human Rotavirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Human Rotavirus Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America Human Rotavirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Human Rotavirus Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa Human Rotavirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Human Rotavirus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Human Rotavirus Vaccine in the World: Market Share by Human Rotavirus Vaccine Revenue in 2021
    Figure 32. Global Human Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
    Figure 34. Global Human Rotavirus Vaccine Revenue Market Share by Type (2017-2028)
    Figure 35. Global Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
    Figure 36. Global Human Rotavirus Vaccine Revenue Market Share by Application (2017-2028)
    Figure 37. North America Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
    Figure 38. North America Human Rotavirus Vaccine Revenue Market Share by Type (2017-2028)
    Figure 39. North America Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
    Figure 40. North America Human Rotavirus Vaccine Revenue Market Share by Application (2017-2028)
    Figure 41. North America Human Rotavirus Vaccine Sales Share by Country (2017-2028)
    Figure 42. North America Human Rotavirus Vaccine Revenue Share by Country (2017-2028)
    Figure 43. U.S. Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
    Figure 46. Europe Human Rotavirus Vaccine Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
    Figure 48. Europe Human Rotavirus Vaccine Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Human Rotavirus Vaccine Sales Share by Country (2017-2028)
    Figure 50. Europe Human Rotavirus Vaccine Revenue Share by Country (2017-2028)
    Figure 51. Germany Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 52. France Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Human Rotavirus Vaccine Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Human Rotavirus Vaccine Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Human Rotavirus Vaccine Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Human Rotavirus Vaccine Revenue Share by Region (2017-2028)
    Figure 62. China Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. India Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Human Rotavirus Vaccine Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Human Rotavirus Vaccine Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Human Rotavirus Vaccine Sales Share by Country (2017-2028)
    Figure 77. Latin America Human Rotavirus Vaccine Revenue Share by Country (2017-2028)
    Figure 78. Mexico Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Human Rotavirus Vaccine Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Human Rotavirus Vaccine Revenue Share by Country (2017-2028)
    Figure 87. Turkey Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E Human Rotavirus Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 90. Human Rotavirus Vaccine Value Chain
    Figure 91. Human Rotavirus Vaccine Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed